Skip to main content
. 2021 Oct 1;8:734735. doi: 10.3389/fnut.2021.734735

Figure 1.

Figure 1

Kaplan–Meier survival curves examining the relationship between pre-treatment albumin and overall survival patients with NSCLC treated with first-line (A) targeted therapy or (B) immunotherapy-based therapy.